// App-Quantinova.ai

: NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUM

Researchers

Presenter

  • Veerle Mondelaers

Principal Investigators

  • Tim Lammens

  • Laurence Dedeken

  • Anne Uyttebroeck

  • Bndicte Brichard

  • Jutte van der Werff ten Bosch

  • Koenraad Norga

  • Nadine Francotte

  • Caroline Piette

  • Yves Benoit

  • Barbara De Moerloose

Medical Centers

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

  • Pediatric Hematology-Oncology,Hôpital Universitaire des Enfants Reine Fabiola (HUDERF-UKZKF),Brussels,Belgium

  • Pediatric Hematology-Oncology,University Hospitals Leuven,Leuven,Belgium

  • Pediatric hematology and oncology, Cliniques universitaires Saint-Luc, Brussels,Belgium

  • Pediatric Hematology-Oncology,University Hospital Brussels,Brussels,Belgium

  • Pediatric Hematology-Oncology,University Hospital Antwerp,Antwerp,Belgium

  • Department of Pediatric Oncology,CHC - Espérence,Liège,Belgium

  • Department of Paediatric Surgery, CHR de la Citadelle, Liege, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Erwinase

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved